Le Lézard
Classified in: Health

Jordi Labs Determines Best Way to Test USP 232 for a Multivitamin Supplement


MANSFIELD, Mass., March 20, 2019 /PRNewswire-PRWeb/ -- The National Institute of Health estimated that Americans spend more than $36 billion on multivitamin supplements each year. But do the vitamins we take really contain the nutrients that are advertised? And how do we know for sure? That's why Jordi Labs conducted an over-the-counter (OTC) multivitamin tablet USP 232 analytical chemistry test to find out.

Jordi completed a study to determine the elemental composition of the vitamin sample using Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Scanning Electron Microscopy with Energy-dispersive X-ray Spectroscopy (SEM-EDS). This was performed by analyzing an over-the-counter multivitamin tablet and comparing the results with the manufacturer's label claim as well as to limits imposed by USP 232.

The study was important because it enabled Jordi Labs to see if the minerals were in the actual vitamins at the levels that appeared on the packaging. The bottom line is that elemental analysis is a powerful tool for characterizing the metal content of a sample but it is important to use the right tool for the right job.

To learn more about Jordi Labs' multivitamin test, or to learn more about Jordi Labs' regulatory support services, visit JordiLabs.com or call 508-819-1540.

About Jordi Labs
Founded in 1980, Jordi Labs provides the highest quality analytical services in the industry. We take pride in helping our customers overcome their analytical challenges by providing excellent service and personal assistance from our highly trained staff.

Contact:
Patrick Burke, Vice President
Jordi Labs
508-966-8010
[email protected]

 

SOURCE Jordi Labs


These press releases may also interest you

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...



News published on and distributed by: